DAPAGLIFLOZIN MODULATES ADROPIN SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE

Category Primary study
JournalJournal of Hypertension
Year 2023
This article has no abstract
Epistemonikos ID: cdc910e7215c878f3e831a76cbda82a423dd5f50
First added on: Feb 16, 2025